Europace, 1099-5129

Journal

View graph of relations

Related Publications
  1. Targeted therapy of underlying conditions improves quality of life in patients with persistent atrial fibrillation: results of the RACE 3 study

    RACE 3 Investigators, Apr-2019, In : Europace. 21, 4, p. 563-571 9 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Performance of idarucizumab as antidote of dabigatran in daily clinical practice

    van der Wall, S. J., van Rein, N., van den Bemt, B., Kruip, M. J. H. A., Meijer, K., te Boome, L. C. J., Simmers, T. A., Alings, A. M., Tieleman, R., Westerweel, P. E., Klok, F. & Huisman, M., Mar-2019, In : Europace. 21, 3, p. 414-420 7 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Incidence and predictors of implantable cardioverter-defibrillator therapy and its complications in idiopathic ventricular fibrillation patients

    Blom, L. J., Visser, M., Christiaans, I., Scholten, M. F., Bootsma, M., van den Berg, M. P., Yap, S-C., van der Heijden, J. F., Doevendans, P. A., Loh, P., Postema, P. G., Barge-Schaapsveld, D. Q., Hofman, N., Volders, P. G. A., Wilde, A. A. & Hassink, R. J., 21-May-2019, In : Europace. 8 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. Sex differences in cardiac arrhythmia: a consensus document of the European Heart Rhythm Association, endorsed by the Heart Rhythm Society and Asia Pacific Heart Rhythm Society

    ESC Sci Document Grp, Oct-2018, In : Europace. 20, 10, p. 1565-1565ao 42 p.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (92) »

ID: 1533233